Invest with Purpose

Essential News

Roche Services and Solutions for the Americas Will Double its Operations in Costa Rica
NEWS

Roche Services and Solutions for the Americas Will Double its Operations in Costa Rica

• Roche announced today that it will hire 370 collaborators throughout this year; will have more than 700 direct employees by the end of 2020.
• As part of Roche’s global strategy, Costa Rica will now provide Human Resources solutions for the Americas.
• The service catalog adds to existing ones for Procurement, Finance, and Information Technologies.

San José, May 21st, 2020. The Swiss-based Pharmaceutical company Roche –a leader in personalized healthcare and the world’s largest biotech company– announced today that it will double the size of its Roche Services andamp; Solutions operations for the Americas, located in San José, Costa Rica. The company will hire 370 new employees throughout 2020 and will have over 700 employees by the end of this year.

Roche established its first operation in Costa Rica more than 45 years ago. In 2017, the company launched its Services andamp; Solutions Operation (Roche Services andamp; Solutions) for the Americas in Escazú Village, providing Information Technology (IT) services and, a year later, expanded its portfolio to the areas of Procurement and Finance. Today, the company reaffirms its confidence and commitment with the country by adding Human Resources services to its portfolio, a project that will grow and consolidate over the next three years.

The People Support Solutions (PSS) area will be added to the current operation to provide Human Resources solutions to Roche employees in the Americas.

The President of Costa Rica, Carlos Alvarado, highlighted that this great investment will have a significant impact on the country’s economy. “We are highly pleased with the increase of Roche’s operations in the country, as this means more job sources and activation of the economy. It is also an acknowledgment of the Costa Rican capabilities and human talent”, the president said.

The Minister of Foreign Trade, Dyalá Jiménez, stated that “the news of Roche’s expansion is greatly pleasing, as today -more than ever- we need to offer new job opportunities to Costa Ricans. It also reflects that a leading company had found in our citizens the necessary capabilities to achieve its objectives. The services sector grew 5% last year compared to 2018, and we expect it will continue to do so. This sector is an opportunity to show to the world that our talent is our hallmark”.

“With the sustained growth in Finance, Procurement and Informatics, and the addition of Human Resources to our service catalog, we foresee ending the year with more than 700 collaborators. The new positions will help us continue providing world-class support for customers throughout the Americas in a variety of languages including English, Spanish, Portuguese, and French. We have found exceptional talent in Costa Rica and these new positions will strengthen our ability to continue fulfilling our commitment to the organization”, said Héctor Feliú, General Manager of Roche Services andamp; Solutions for the Americas.

CINDE General Director Jorge Sequeira Picado added that “we have witnessed since 2017 the remarkable growth of Roche Services andamp; Solutions in Costa Rica. Today, the company announces that it will double the number of employees in the country, which will increase the services provided for the Americas. This demonstrates the Costa Rican human talent capabilities working in the services sector, a talent that is multilingual, and qualified in high-demand professional areas of Industry 4.0. To date, more than 72,559 people are formally employed in companies belonging to this sector. We appreciate Roche’s trust in our country.”

A Company with Multiple Benefits
Roche is a company that encourages its employees to develop their professional careers and maximize their potential through local and/or international growth. Employees from more than 15 different nationalities work at Roche Services andamp; Solutions, providing support and solutions in Spanish, English, Portuguese, and French.

Diversity and inclusion are also part of the company’s core principles, as a means to create an environment that fosters innovation. At Roche Services andamp; Solutions Operations Americas, currently, 52% of leadership positions are held by women, and 18% of the site employees are over 40 years of age.

Roche offers an attractive benefits package that includes life and medical insurance plans, a scholarship program, extended maternity and paternity leaves, and a dental benefit, among others. The company also provides a flexible benefits package and a “Asociación Solidarista.”

For this expansion, talent acquisition will continue throughout 2020. Open positions are available in all areas that currently provide support at Roche Services andamp; Solutions in San José: Finance, Procurement, IT, and Human Resources.

Some of the current positions that require bilingual and trilingual staff (Spanish, English, Portuguese, and/or French) are:

French Tandamp;E Compliance Analyst, SAP FICO Business Support Analyst, Accounts Payable Analyst (Portuguese), Trilingual ASK HR Team Lead, Trilingual Ask HR Specialist LATAM, Network Specialist, Data Management Senior, and Secure Access (IAM andamp; Security) Expert.

Those who wish to apply can do so directly at https://www.roche.com/careers
Roche invites all interested applicants to visit the site often, as new job opportunities will be added throughout the year (search for opportunities in Costa Rica).

About Roche
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalized healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.

Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in-vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.

Founded in 1896, Roche continues to search for better ways to prevent, diagnose, and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. More than thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials, and cancer medicines. Moreover, for the eleventh consecutive year, Roche has been recognized as one of the most sustainable companies in the Pharmaceuticals Industry by the Dow Jones Sustainability Indices (DJSI).

The Roche Group, headquartered in Basel, Switzerland, is active in over 100 countries and in 2019 employed about 98,000 people worldwide. In 2019, Roche invested CHF 11.7 billion in Randamp;D and posted sales of CHF 61.5 billion. Genentech, in the United States, is a wholly-owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan. For more information, please visit www.roche.com.